Qvella is a leading brand that aims to revolutionize clinical decisions for better patient outcomes. With their innovative FAST Technology (Field Activated Sample Treatment), Qvella facilitates the automation and acceleration of microbiology workflow, providing actionable information for bloodstream infections in minutes. Their FAST PBC Prep Cartridge prepares a Liquid Colony™ from a PBC in just 30 minutes, comparable to a solid colony.

The FAST System, on the other hand, detects over 90% of pathogens causing Sepsis directly from blood in less than one hour. Qvella's commitment to speed and accuracy aligns with guidelines from the Surviving Sepsis Campaign and the UK National Institute for Health and Care Excellence, which recommend antimicrobial therapy within 1 hour of sepsis diagnosis. Each hour of delay in appropriate antibiotic therapy increases mortality by 7.

6%, underlining the urgency Qvella's technology addresses. Stay up to date with Qvella's breakthroughs by checking out their News & Events page. Trust Qvella to deliver quick and reliable solutions because, when it comes to sepsis, every minute counts